(Q43011861)

12 November 2017

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer (English)

1 reference

12 November 2017

1 reference

cognitive dysfunction

1 reference

3

Aman U Buzdar

1 reference

12 November 2017

Jeffrey S Wefel

1

1 reference

12 November 2017

Angele K Saleeba

series ordinal

2

1 reference

12 November 2017

Christina A Meyers

series ordinal

4

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

12 November 2017

1 reference

12 November 2017

116

1 reference

12 November 2017

14

1 reference

12 November 2017

3348-3356

1 reference

5-fluorouracil-induced leukoencephalopathy in patients with breast cancer

12 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

Transient encephalopathy after paclitaxel (Taxol) infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

Benton Controlled Oral Word Association Test: reliability and updated norms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

Neurological complications of radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Letter: Organic mental changes with fluorouracil therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Taxol-induced neuropathy: chronic effects of local injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: a review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Acute transient encephalopathy after paclitaxel infusion: report of three cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Cognitive impairment associated with adjuvant therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

'Chemobrain' in breast carcinoma?: a prologue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Cognitive function in breast cancer patients prior to adjuvant treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Practice effects during repeated administrations of memory tests with and without alternate forms.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Improvement or simply practice? The effects of twenty repeated assessments on people with and without brain injury

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Detecting significant change in neuropsychological test performance: a comparison of four models

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Neuropathologic study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dogs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Metabolites of 5-fluorouracil, alpha-fluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Cytosine arabinoside treatment impairs the remote spatial memory function and induces dendritic retraction in the anterior cingulate cortex of rats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Hippocampal brain amines in methotrexate-induced learning and memory deficit

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Normative data for determining significance of test-retest differences on eight common neuropsychological instruments.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25098

7 January 2021

Identifiers

DOI

10.1002/CNCR.25098

1 reference

release_ou5lza2wezd5rbiugnyvvryeyy

12 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ou5lza2wezd5rbiugnyvvryeyy

24 November 2022

mapped directly with Wikidata item

1 reference